What is Stargardt Disease and How Does It Affect My Dog
- Kim Casey

- Dec 30, 2025
- 3 min read
Updated: 6 days ago

Stargardt Disease is a genetic eye disorder that has gained attention in the canine world, particularly among Labrador Retrievers and related breeds. While the name may sound intimidating, understanding the condition in layman’s terms helps dog owners make informed decisions about testing, breeding, and care.
What is Stargardt Disease and how does it affect my dog
At its core, Stargardt Disease is a degenerative retinal condition. The retina is the light‑sensitive tissue at the back of the eye, responsible for converting light into signals that the brain interprets as vision. In dogs with Stargardt Disease, mutations in the ABCA4 gene cause the gradual breakdown of rod and cone cells. Rods help dogs see in dim light, while cones allow them to perceive detail and color in bright light. As these cells deteriorate, affected dogs experience progressive vision loss.

Research shows that the ABCA4 mutation leads to lipofuscin accumulation in the retinal pigment epithelium, which contributes to photoreceptor degeneration. This mirrors the mechanism of human Stargardt disease, making dogs an important comparative model for study.
Unlike sudden blindness, Stargardt Disease progresses slowly. Dogs may begin showing signs such as bumping into furniture, hesitating on stairs, or struggling to fetch toys. Owners often notice these changes between 1–2 years of age, though some dogs are not diagnosed until middle age.
Genetic Basis and Inheritance
The disease follows an autosomal recessive inheritance pattern. This means a dog must inherit two copies of the mutated gene—one from each parent—to be at risk of developing symptoms. Dogs with only one copy are considered carriers. They typically do not show vision problems but can pass the mutation to their offspring.

Genetic testing has revealed that approximately 1 in 64 Labrador Retrievers carries the Stargardt variant. However, not all carriers develop symptoms. Only dogs with two copies of the mutation (homozygous) are likely to show clinical signs.
This distinction is crucial for breeders and owners: while carriers are relatively common, the actual percentage of dogs that develop noticeable vision loss is significantly lower.
How Stargardt Disease Affects Daily Life
For affected dogs, Stargardt Disease is non‑painful. They don’t suffer discomfort, but their world gradually becomes less clear.

Despite these challenges, many dogs retain partial vision throughout their lives and adapt remarkably well. Dogs rely heavily on their sense of smell and hearing, which remain unaffected. With patience and environmental adjustments—like keeping furniture in consistent places, using textured floor runners, and adding verbal cues—dogs with Stargardt Disease can live fulfilling, confident lives.
Prevalence and Risk Percentages
Here’s where the numbers matter:
Carrier frequency: Roughly 1.5% of tested Labradors carry the mutation
Symptomatic dogs: Only those with two copies (homozygous) develop clinical signs
This means that while genetic testing may reveal carriers, the actual risk of widespread blindness in the breed is relatively low. Still, responsible breeding practices—such as avoiding carrier‑to‑carrier pairings—are essential to reduce the chance of producing affected puppies.
Veterinary Diagnosis and Management
Veterinarians diagnose Stargardt Disease through:
ophthalmic exams
genetic testing
advanced imaging such as electroretinography (ERG) or optical coherence tomography (OCT)
While there is no cure, supportive care focuses on helping dogs adapt. Owners can work with veterinary ophthalmologists to monitor progression and ensure their dog’s comfort.
The International Working Dog Breeding Association (IWBDA) provides additional context on inheritance and retinal structure in an image fortified visual aid that walks through the disease in a helpful slide deck.
Summary

In short, What is Stargardt Disease and how does it affect my dog? It’s a genetic eye condition caused by mutations in the ABCA4 gene, leading to gradual vision loss. While about 1 in 64 dogs may carry the mutation, only those with two copies develop symptoms. The disease is non‑painful, and with supportive care, affected dogs can live happy, adapted lives.
For owners, breeders, and trainers, understanding Stargardt Disease empowers better decision‑making—ensuring dogs receive the support, compassion, and thoughtful breeding practices they deserve.







Comments